MelioLabs
Business Services · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
melio.techRevenue
<$5 MillionIndustry
About MelioLabs
Melio develops a culture-free, rapid bloodborne pathogen testing platform designed to identify pathogens in hours rather than days. The technology integrates a proprietary assay, microfluidics, and machine-learning techniques to enable direct-from-blood diagnostic testing without the need for targeted probes. The system utilizes DNA melting technology to capture unique DNA melt curves, which are then classified via AI-driven analytics. Melio specifically targets applications for newborns in the NICU to reduce the use of unnecessary antibiotics. The solution is designed to detect Gram-positive and Gram-negative bacteria, fungi, viruses, and antimicrobial resistance markers, with new detection capabilities delivered via software updates.Explore more
MelioLabs Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
MelioLabs Tech Stack
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding MelioLabs
Sign Up For FreeTo access detailed company insights
Melio develops a culture-free, rapid bloodborne pathogen testing platform designed to identify pathogens in hours rather than days. The technology integrates a proprietary assay, microfluidics, and machine-learning techniques to enable direct-from-blood diagnostic testing without the need for targeted probes. The system utilizes DNA melting technol... Read More
